Showing results (351-360 of 687) with videos related to
Sort By:
Pageof 69
Journal of Bone Oncology|November 19, 2015
Use of urinary markers in cancer setting: A literature reviewLeonard Chiu, Erin Wong, Carlo DeAngelis, et al.Journal of Bone Oncology|November 19, 2015
Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meetingCarmel Jacobs, Eitan Amir, Alexander Paterson, et al.Journal of Bone Oncology|January 6, 2016
Surface osteosarcoma: Clinical features and therapeutic implicationsH Nouri, M Ben Maitigue, L Abid, et al.Journal of Bone Oncology|March 22, 2016
Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signalingChangfu Zhao, Qiao Zhang, Tao Yu, et al.Journal of Bone Oncology|August 2, 2018
Variants of FasL and ABCC5 are predictive of outcome after chemotherapy-based treatment in osteosarcomaLeilei Xu, Chao Xia, Qi Sun, et al.Journal of Bone Oncology|July 3, 2018
Does intensified chemotherapy increase survival outcomes of osteosarcoma patients? A meta-analysisYa Zhang, Zewei He, Yanping Duan, et al.Journal of Bone Oncology|October 6, 2021
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic targetJun-Hua Nie, Tao Yang, Hong Li, et al.Journal of Bone Oncology|October 29, 2021
Long non-coding RNA KRT8P41/miR-193a-3p/FUBP1 axis modulates the proliferation and invasion of chordoma cellsHai Wen, Yang Fu, Yapeng Zhu, et al.Journal of Bone Oncology|October 29, 2021
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer originShimaa Ahmed, Shereen M Kamal, Tareq Salah, et al.Journal of Bone Oncology|October 27, 2021
Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markersChunliu Meng, Jia Wei, Jia Tian, et al.Pageof 69